This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008 Jul;16(7):523-7.

doi: 10.1097/JGP.0b013e318178416c.

Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?

Helen Lavretsky

PMID: 18591572
PMCID: PMC2806814
DOI: 10.1097/JGP.0b013e318178416c

Editorial

Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?

Helen Lavretsky. Am J Geriatr Psychiatry. 2008 Jul.

. 2008 Jul;16(7):523-7.

doi: 10.1097/JGP.0b013e318178416c.

Author

Helen Lavretsky

PMID: 18591572
PMCID: PMC2806814
DOI: 10.1097/JGP.0b013e318178416c

No abstract available

PubMed Disclaimer

Similar articles

Behavioral and psychological symptoms of dementia and medical treatment.
Amano N, Inuzuka S, Ogihara T. Amano N, et al. Psychogeriatrics. 2009 Jun;9(2):45-9. doi: 10.1111/j.1479-8301.2009.00284.x. Psychogeriatrics. 2009. PMID: 19604324 Review. No abstract available.
Problems and prospects in the treatment of dementia.
Dagon EM, Liebman A. Dagon EM, et al. Wis Med J. 1982 Aug;81(8):32-4. Wis Med J. 1982. PMID: 6753350 Review. No abstract available.
Alzheimer dementia: Starting, stopping drug therapy.
Kim LD, Factora RM. Kim LD, et al. Cleve Clin J Med. 2018 Mar;85(3):209-214. doi: 10.3949/ccjm.85a.16080. Cleve Clin J Med. 2018. PMID: 29522388 Review.
Behavior as an efficacy outcome.
Cummings JL. Cummings JL. Alzheimer Dis Assoc Disord. 1997;11 Suppl 4:v-vi. Alzheimer Dis Assoc Disord. 1997. PMID: 9339265 No abstract available.
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
Burns A, O'Brien J; BAP Dementia Consensus group; Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D; British Association for Psychopharmacology. Burns A, et al. J Psychopharmacol. 2006 Nov;20(6):732-55. doi: 10.1177/0269881106068299. J Psychopharmacol. 2006. PMID: 17060346 Review.

See all similar articles

Cited by

Non-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias.
Barton C, Ketelle R, Merrilees J, Miller B. Barton C, et al. Curr Neurol Neurosci Rep. 2016 Feb;16(2):14. doi: 10.1007/s11910-015-0618-1. Curr Neurol Neurosci Rep. 2016. PMID: 26750129 Free PMC article. Review.
Can persons with dementia be engaged with stimuli?
Cohen-Mansfield J, Marx MS, Dakheel-Ali M, Regier NG, Thein K. Cohen-Mansfield J, et al. Am J Geriatr Psychiatry. 2010 Apr;18(4):351-62. doi: 10.1097/jgp.0b013e3181c531fd. Am J Geriatr Psychiatry. 2010. PMID: 20306565 Free PMC article.
REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.
Robert PH, Mulin E, Malléa P, David R. Robert PH, et al. CNS Neurosci Ther. 2010 Oct;16(5):263-71. doi: 10.1111/j.1755-5949.2009.00132.x. CNS Neurosci Ther. 2010. PMID: 20345973 Free PMC article. Review.
Behavioral disturbance in dementia.
Desai AK, Schwartz L, Grossberg GT. Desai AK, et al. Curr Psychiatry Rep. 2012 Aug;14(4):298-309. doi: 10.1007/s11920-012-0288-5. Curr Psychiatry Rep. 2012. PMID: 22644311
Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?
Van Dam D, Vermeiren Y, Dekker AD, Naudé PJ, Deyn PP. Van Dam D, et al. Curr Alzheimer Res. 2016;13(10):1145-64. doi: 10.2174/1567205013666160502123607. Curr Alzheimer Res. 2016. PMID: 27137218 Free PMC article. Review.

References

1. Ferri CP, Prince M, Brayne C, et al. Alzheimer’s Disease International Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–2117. - PMC - PubMed
1. Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000;157:708–714. - PubMed
1. Matsui T, Nakaaki S, Murata Y, et al. Determinants of the quality of life in Alzheimer’s disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer’s disease scale. Dement Geriatr Cogn Disord. 2006;21:182–191. - PubMed
1. Jeste DV, Blazer D, Casey D, et al. ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology. 2008;33:957–970. - PMC - PubMed
1. Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer’s disease: seeking the neurobiological basis. Neurobiol Aging. 2000;21:845–861. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

R-21 AT003480/AT/NCCIH NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information